Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate and Sarilumab Subcutaneous
Determining the interaction of Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate
Brand name: Azuphen MB, Hyolev MB, Phosphasal, UR N-C, Uramit MB, Urelle, Uribel, Urimar-T, Urin D/S, Uro-L, Ustell, Utira-C, Uro-MP, Vilamit MB, Vilevev MB, UR N-C, Urelle, Uretron D/S, Urin DS, Uro-458, UroAv-81, UroAv-B, Uticap, Utrona-C
Synonyms: Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate-Sarna Hc Topical application
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate-Sarnol-HC
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate-Sarnol-HC Maximum Strength
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate-SAStid
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate-Sastid Soap Topical
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate-SAStid Topical
- Sarilumab Subcutaneous-Hyosophen
- Sarilumab Subcutaneous-Hyosyne
- Sarilumab Subcutaneous-Hyosyne Elixir
- Sarilumab Subcutaneous-Hypaque
- Sarilumab Subcutaneous-Hypaque Injection
- Sarilumab Subcutaneous-Hypaque Meglumine